OTC : LJUIF

SSY Group Limited

$0.40255 USD

$0 (0.0%)

Volume
700
Average Volume
638
Market Capitalization
$1.19B
P/E Ratio
15.16
Dividend Yield
3.29%
Price Target
Year High
$0.70
Year Low
$0.40
Day High
Day Low
Payout Ratio
$0.91
Current Ratio
$1.89
Company Overview

OTC

Jiguang Qu

Drug Manufacturers - Specialty & Generic

Healthcare

LJUIF

5500

HK

USD

852 2688 0869

G8406X103

N/A

Liquidity Metrics

0.55

1.89

1.43

0.68

0.91

Sales & Valuation

$4.16B

1.69

0.97

13.25

0.18

Profitability

$0.16

$470.53M

11.30%

13.53%

6.46%

3.67%

P/E Metrics

15.16

-0.27

-0.27

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

3.31

4/9

$2.34B

$12.81B

$5.19B

$1.87B

Key Metrics (TTM)

$9.36B

2.25

9.04

1.89

6.46%

4.51%

6.56%

7.46%

$3.01

287 days

Company Executives
Name Title
Guo Meng Deputy GM & Executive Director
Wanrong Qu Deputy GM & Executive Director
Hing Yeung Chow Chief Financial Officer, Company Secretary & Executive Director
Jiguang Qu Executive Chairman & Chief Executive Officer
Xuejun Su Executive Director
Poll Results

No votes yet today — be the first to share your view!

About SSY Group Limited (OTC:LJUIF) Stock

SSY Group Limited functions as an investment holding company, primarily focused on the research, development, manufacturing, and distribution of a wide array of pharmaceutical goods. Its products reach hospitals and distributors across the People's Republic of China and international markets. The company's extensive product portfolio encompasses various intravenous (IV) infusion solutions, including formulations in non-PVC soft bags, upright soft bags, robust PP plastic bottles, and traditional glass bottles. It also provides ampoule and small volume injections, oral preparations, and both traditional Chinese and biological medicines. Furthermore, SSY Group supplies bulk pharmaceutical ingredients and essential medical materials. Beyond pharmaceuticals, the company engages in pharmaceutica ... l technology research, development, and consulting services, alongside offering logistics support for its medical products. Uniquely, it also holds interests in the food, beverages, and catering sectors. Many of its offerings are marketed under the 'Shimen' brand. Established in 2004, the firm was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. before adopting the SSY Group Limited name in May 2015. It maintains its corporate headquarters in Wanchai, Hong Kong, and operates as a subsidiary of China Pharmaceutical Co., Ltd.

Frequently Asked Questions

What is the current SSY Group Limited (LJUIF) stock price?

SSY Group Limited(OTC:LJUIF) stock price is $0.40255 in the last trading session. During the trading session, LJUIF stock reached the peak price of $0.6987 while $0.40255 was the lowest point it dropped to. The percentage change in LJUIF stock occurred in the recent session was 0.0% while the dollar amount for the price change in LJUIF stock was $0.

LJUIF's industry and sector of operation?

The OTC listed LJUIF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of LJUIF?

Guo Meng | Deputy GM & Executive Director
Wanrong Qu | Deputy GM & Executive Director
Hing Yeung Chow | Chief Financial Officer, Company Secretary & Executive Director
Jiguang Qu | Executive Chairman & Chief Executive Officer
Xuejun Su | Executive Director

How many employees does LJUIF have?

Number of LJUIF employees currently stands at 5500. LJUIF operates from Central Plaza, Wan Chai, None None, HK.

Link for LJUIF official website?

Official Website of LJUIF is: https://www.ssygroup.com.hk

How do I contact LJUIF?

LJUIF could be contacted at phone #852 2688 0869 and can also be accessed through its website. LJUIF operates from Central Plaza, Wan Chai, None None, HK.

How many shares of LJUIF are traded daily?

The average number of LJUIF shares traded daily for last 3 months was 638.

What is the market cap of LJUIF currently?

The market value of LJUIF currently stands at $1.19B with its latest stock price at $0.40255